Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 21;22(1):3.
doi: 10.1007/s11904-024-00711-2.

Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV

Affiliations
Review

Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV

Jessica A Alvarez et al. Curr HIV/AIDS Rep. .

Abstract

Purpose of review: As advances in antiretroviral therapy for people with HIV (PWH) have prolonged lifespans, prevalence of aging and obesity related metabolic disorders have increased. The purpose of this review is to summarize recent research assessing sex differences in metabolic disorders among PWH, including weight gain/obesity, steatotic liver disease, insulin resistance/diabetes, dyslipidemia, bone loss/osteoporosis, and sarcopenia.

Recent findings: A growing body of evidence shows that women with HIV are at increased risk of developing metabolic disorders compared to men, including body weight gain and obesity, type 2 diabetes mellitus, dyslipidemia, bone loss, and sarcopenia, while men with HIV are at higher risk for hepatosteatosis and hepatic fibrosis. Future work should prioritize the adequate representation of women in HIV clinical studies. Understanding sex-specific mechanisms underlying metabolic dysfunction in PWH is imperative so that interventions can be developed to address a growing global epidemic of metabolic diseases.

Keywords: Aging; HIV; Metabolic; Obesity; Sex differences.

PubMed Disclaimer

Conflict of interest statement

Declarations. Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by any of the authors. Competing Interests: Dr. Cecile Lahiri has received grants from Merck Pharmaceuticals and serves as a consultant and advisory board member for Theratechnologies, Inc. Dr. Alvarez, Ms. Ojuri, Mr. Buckley, Dr. Bedi, Dr. Musonge-Effoe, and Ms. Soibi-Harry declare that they have no conflicts of interest.

References

    1. Autenrieth CS, Beck EJ, Stelzle D, Mallouris C, Mahy M, Ghys P. Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000–2020. PLoS One. 2018;13(11):e0207005. doi: 10.1371/journal.pone.0207005. - DOI - PMC - PubMed
    1. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–6. doi: 10.1093/cid/cir627. - DOI - PubMed
    1. Curno MJ, Rossi S, Hodges-Mameletzis I, Johnston R, Price MA, Heidari S. A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies. J Acquir Immune Defic Syndr. 2016;71(2):181–8. doi: 10.1097/QAI.0000000000000842. - DOI - PubMed
    1. Collins LF, Palella FJ Jr., Mehta CC, Holloway J, Stosor V, Lake JE, et al. Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008–2019. JAMA Netw Open. 2023;6(8):e2327584. doi: 10.1001/jamanetworkopen.2023.27584.

      This study in the U.S. MACS/WIHS cohort highlighted the higher burden of age-related comorbidities among women living with HIV in the US.

    1. Bailin SS, Gabriel CL, Wanjalla CN, Koethe JR. Obesity and Weight Gain in Persons with HIV. Curr HIV/AIDS Rep. 2020;17(2):138–50. doi: 10.1007/s11904-020-00483-5. - DOI - PMC - PubMed

LinkOut - more resources